Anthem, Inc. (ANTM)
(Delayed Data from NYSE)
$261.70 USD
+0.11 (0.04%)
Updated May 3, 2019 04:00 PM ET
After-Market: $261.69 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGMWe use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$261.70 USD
+0.11 (0.04%)
Updated May 3, 2019 04:00 PM ET
After-Market: $261.69 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGM
Zacks News
Anthem (ANTM) Buys MMM & Other Units From InnovaCare Health
by Zacks Equity Research
Anthem (ANTM) purchases subsidiaries of InnovaCare Health to facilitate better health outcomes across Puerto Rico.
Is Anthem (ANTM) a Great Value Stock Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
UnitedHealth (UNH) Unit Opens Clinic to Ease Healthcare Access
by Zacks Equity Research
UnitedHealth Group's (UNH) subsidiary Optum launches Optum Mobile Clinic, which aims to facilitate easy access to quality healthcare services across 10 U.S. counties.
Magellan's (MGLN) Unit Ties Up to Boost ASD Patient Outcomes
by Zacks Equity Research
Magellan Health's (MGLN) unit - Magellan Healthcare - collaborated with Invo Healthcare for improving the model that provides ABA treatment to autistic children.
Humana (HUM) to Buy onehome to Expand in Homehealth Care
by Zacks Equity Research
Humana (HUM) to take over One Homecare Solutions to establish its dominance in the home health business.
Humana (HUM), League Tie Up for a Digital Health Platform
by Zacks Equity Research
Humana (HUM) teams up with League to launch a digital health and benefits platform for boosting customer experience.
Top Research Reports for Intel, NextEra Energy & PetroChina
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including Intel (INTC), NextEra Energy (NEE), and PetroChina Company (PTR).
Why Should You Retain Anthem (ANTM) Stock in Your Portfolio?
by Zacks Equity Research
Riding high on its inorganic growth story and an improving membership, Anthem (ANTM) holds enough potential to reap benefits for investors.
UnitedHealth's (UNH) Sub-unit to Offer Cancer Care in Texas
by Zacks Equity Research
UnitedHealth Group's (UNH) subsidiary Optum, through its division USMD, intends to offer enhanced and cost-effective cancer treatment across Texas.
Anthem (ANTM) Up 3% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Anthem (ANTM) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Anthem (ANTM), Epic Collaborate for Better Consumer Experience
by Zacks Equity Research
Anthem (ANTM) teams up with health information company Epic for bridging the gaps in medical care with near real-time data.
Zacks Industry Outlook Highlights: UnitedHealth Group, Anthem, Cigna Corp and Humana
by Zacks Equity Research
Zacks Industry Outlook Highlights: UnitedHealth Group, Anthem, Cigna Corp and Humana
4 HMO Stocks in Focus as Legislative, Operating Trends Improve
by Sapna Bagaria
Health insurers are poised for long-term growth on the back of political support, aging demographics, investment in technology.
Select Medical (SEM) Banks on Top-Line Growth, Solid Cash Flows
by Zacks Equity Research
Select Medical (SEM) gains from constant top-line growth, strong 2021 business outlook and solid cash balance.
If You Invested $1000 in Anthem a Decade Ago, This is How Much It'd Be Worth Now
by Zacks Equity Research
Holding on to popular or trending stocks for the long-term can make your portfolio a winner.
Cigna (CI) Q1 Earnings Beat Mark, Rise Y/Y on Revenue Gains
by Zacks Equity Research
Cigna's (CI) Q1 results reflect higher pharmacy revenues, and fees and other income.
Magellan Health's (MGLN) Q1 Earnings Beat Mark, Improve Y/Y
by Zacks Equity Research
Magellan Health's (MGLN) Q1 results reflect better performances by its Heathcare and Pharmacy Management segments.
Molina Healthcare's (MOH) Q1 Earnings Top Estimates, Rise Y/Y
by Zacks Equity Research
Molina Healthcare's (MOH) first-quarter earnings gain from higher revenues and increased membership in Medicaid and Marketplace.
Universal Health (UHS) Q1 Earnings Top, Revenues Improve Y/Y
by Zacks Equity Research
Universal Health's (UHS) first-quarter results highlight uptick in revenues across both the company's segments, partly offset by escalating costs.
Humana (HUM) to Report Q1 Earnings: What's in the Cards?
by Zacks Equity Research
Humana's (HUM) first-quarter results are likely to reflect better revenues and strong Medicaid and Medicare businesses, partly offset by Specialty business and high costs.
What's in Offing for Teladoc Health's (TDOC) Earnings in Q1?
by Zacks Equity Research
Teladoc's (TDOC) Q1 results are likely to reflect higher revenues, partly offset by inflated expenses.
What's in Store for Universal Health's (UHS) Q1 Earnings?
by Zacks Equity Research
Universal Health's (UHS) first-quarter earnings are expected to have gained from better revenues and performances by its Acute Care and Behavioral Health segments.
HCA Healthcare's (HCA) Q1 Earnings Beat, Revenues Up Y/Y
by Zacks Equity Research
HCA Healthcare's (HCA) first-quarter results highlight higher revenues, partly offset by increased costs.
Company News for Apr 22, 2021
by Zacks Equity Research
Companies In The News Are: ANTM, TEL, LAD, RCI
Anthem's (ANTM) Q1 Earnings Beat Estimates, Increase Y/Y
by Zacks Equity Research
Anthem's (ANTM) Q1 earnings gain from better revenues and strong Medicaid and Medicare businesses.